Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma

Published Date: 06 Jan 2025

Studies show promising EFS, PFS, and OS at 3 to 8 years

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A specific drug combination is being tested in a clinical trial for the deadly brain cancer glioblastoma.

2.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

3.

Cancerous breast tissue glows in new AI-enhanced MRI images

4.

Study finds common genetic target may halt breast cancer cell growth

5.

Pickleball program boosts health and wellness for cancer survivors, study finds


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot